Clearance III-IV- Hepatic+Renal

Clearance III-IV- Hepatic+Renal - Clearance III IV Hepatic...

Info iconThis preview shows pages 1–12. Sign up to view the full content.

View Full Document Right Arrow Icon
1 Clearance III – IV Hepatic and Renal
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
2 Practice Problems From Book Drug Monograph 9 – Phenobarbital Questions 1-5 Don’t get hung up on e -kt Should understand the gist of the intro material
Background image of page 2
3 HERD Q H Cl int E Cl H C pss,avg L/min L/min L/min mg/L 1.5 10 0.87 1.30 0.77 1.0 10 0.91 0.91 1.10 1.5 20 0.93 1.40 - 0.77 - LERD 1.5 0.01 0.0066 0.0099 101 1.0 0.01 0.0099 0.0099 101 - 1.5 0.2 0.013 0.0195 51
Background image of page 3

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
4 Some Lessons LERD: Cl and blood levels won’t change much if liver perfusion changes – will change if Cl int changes may need to increase dosage (notice that E doesn’t go hand in hand with Cl) HERD: Cl and blood levels will change if liver perfusion changes – won’t change much if Cl int changes (and won’t need to change the dosage) (notice that E doesn’t go hand in hand with Cl)
Background image of page 4
5 Liver and Oral Dosing F – bioavailability – F H – fraction that makes it through the liver hepatic availability – (if 100% absorption F H = F total bioavailability ) • F H = 1-E HERD E ~1.0 – little bioavailability but a small change proportionately important e.g. 0.04 0.08 Not important if iv, im, sc dosing (before) but is potentially important if oral dosing
Background image of page 5

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
6 Protein Binding Assume only unbound drug can get into liver cell and be cleared (there are exceptions) – Previously Cl int innate ability to clear but cant clear total drug only unbound SO multiply by fu • fu*Cl int,u same equations except fu incorporated
Background image of page 6
7 Protein Binding • E= fu*CL int,u / (Q H + fu*Cl int,u ) • CL H = Q H * fu*CL int,u / (Q H + fu*Cl int,u ) • LERD – fu*CL int,u << Q H Then (by analogy to before)- – CL H = ~fu*CL int,u What about changes in binding?? low proteins in disease (e.g. uremia) something displaces the drug from it’s binding in both cases fu goes up
Background image of page 7

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
8 An Example - LERD Cl int,u = 0.25 L/min, fu=0.1 Q H =1.5 • R 0 =0.25 mg/min E= 0.0164 Cl H = 1.5 l/min * 0.0164 = 0.0246 Don’t get confused – calculating total hepatic clearance (total drug) used fu to calculated fraction available inside liver
Background image of page 8
9 Same Example -LERD • CL H = 0.0246 L/min Blood levels – C pss,avg = R 0 / Cl H =0.25 mg/min / 0.0246 L/min = 10.2 mg/L (this is total drug)
Background image of page 9

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
10 What if fu changes LERD fu = 0.2 E= 0.0322 it’s gone up ~ 2 fold why? – amount unbound has gone up • Cl H = 1.5 l/min * 0.0322 = 0.0483 it’s gone up ~ 2 fold why? – amount unbound has gone up
Background image of page 10
11 What if fu changes - LERD CL
Background image of page 11

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 12
This is the end of the preview. Sign up to access the rest of the document.

This note was uploaded on 08/26/2010 for the course PHRM 231 taught by Professor N/a during the Fall '07 term at UConn.

Page1 / 42

Clearance III-IV- Hepatic+Renal - Clearance III IV Hepatic...

This preview shows document pages 1 - 12. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online